Estimates of anti-SARS-CoV-2 antibody seroprevalence in Iran
Lancet Infect Dis
.
2021 May;21(5):602-603.
doi: 10.1016/S1473-3099(21)00053-0.
Epub 2021 Feb 15.
Authors
Mahan Ghafari
1
,
Alireza Kadivar
2
,
Aris Katzourakis
3
Affiliations
1
Department of Zoology, University of Oxford, Oxford, UK. Electronic address: mahan.ghafari@zoo.ox.ac.uk.
2
Center for Statistics and Operation Research, Statsminute, Tehran, Iran.
3
Department of Zoology, University of Oxford, Oxford, UK. Electronic address: aris.katzourakis@zoo.ox.ac.uk.
PMID:
33600759
PMCID:
PMC7906708
DOI:
10.1016/S1473-3099(21)00053-0
No abstract available
Publication types
Letter
Comment
MeSH terms
Antibodies, Viral
COVID-19*
Cities
Cross-Sectional Studies
Humans
Iran / epidemiology
SARS-CoV-2*
Seroepidemiologic Studies
Substances
Antibodies, Viral